These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 21088095

  • 21. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
    Heitmann J, Greulich T, Reinke C, Koehler U, Vogelmeier C, Becker HF, Schmidt AC, Canisius S.
    Curr Med Res Opin; 2010 Aug; 26(8):1925-32. PubMed ID: 20560730
    [Abstract] [Full Text] [Related]

  • 23. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I.
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [Abstract] [Full Text] [Related]

  • 24. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 25. [Nebivolol treatment in essential arterial hypertension].
    Ghiuru R, Rezuş C, Ambăruş V, Ionescu S, Cosovanu A.
    Rev Med Chir Soc Med Nat Iasi; 2001 Mar 15; 105(4):756-9. PubMed ID: 12092233
    [Abstract] [Full Text] [Related]

  • 26. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec 15; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 27. Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study.
    Van Bortel LM.
    Eur Rev Med Pharmacol Sci; 2010 Sep 15; 14(9):749-58. PubMed ID: 21061833
    [Abstract] [Full Text] [Related]

  • 28. Nebivolol: new therapy update.
    Sule SS, Frishman W.
    Cardiol Rev; 2006 Sep 15; 14(5):259-64. PubMed ID: 16924166
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B.
    Adv Ther; 2008 Jun 15; 25(6):619-26. PubMed ID: 18563311
    [Abstract] [Full Text] [Related]

  • 30. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.
    Clin Exp Pharmacol Physiol; 2007 Apr 15; 34(4):327-31. PubMed ID: 17324145
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
    Rosei EA, Rizzoni D, Comini S, Boari G, Nebivolol-Lisinopril Study Group.
    Blood Press Suppl; 2003 May 15; 1():30-5. PubMed ID: 12800985
    [Abstract] [Full Text] [Related]

  • 32. [Young patient with mild hypertension: angiotensin inhibitor or beta blocker?].
    Girndt M.
    MMW Fortschr Med; 2011 Sep 22; 153(38):17. PubMed ID: 21977791
    [No Abstract] [Full Text] [Related]

  • 33. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.
    J Hum Hypertens; 1997 Nov 22; 11(11):753-7. PubMed ID: 9416986
    [Abstract] [Full Text] [Related]

  • 34. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y, Arnott W.
    J Hum Hypertens; 1994 Apr 22; 8(4):283-8. PubMed ID: 8021909
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
    Van Bortel LM, Fici F, Mascagni F.
    Am J Cardiovasc Drugs; 2008 Apr 22; 8(1):35-44. PubMed ID: 18303936
    [Abstract] [Full Text] [Related]

  • 36. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM, Keam SJ.
    Am J Cardiovasc Drugs; 2009 Apr 22; 9(4):253-60. PubMed ID: 19655820
    [Abstract] [Full Text] [Related]

  • 37. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T, Heise T, Nosek L, Eckers U, Sawicki PT.
    J Hypertens; 2006 Jul 22; 24(7):1397-403. PubMed ID: 16794490
    [Abstract] [Full Text] [Related]

  • 38. Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial.
    Giles TD, Khan BV, Lato J, Brener L, Ma Y, Lukic T.
    J Clin Hypertens (Greenwich); 2013 Sep 22; 15(9):687-93. PubMed ID: 24034663
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patients.
    Marazzi G, Volterrani M, Caminiti G, Iaia L, Cacciotti L, Massaro R, Sposato B, Vitale C, Mercuro G, Rosano G.
    Adv Ther; 2010 Sep 22; 27(9):655-64. PubMed ID: 20690006
    [Abstract] [Full Text] [Related]

  • 40. [Experience of the use of nebivolol in the treatment of hypertension in postmenopausal women].
    Bart BIa, Benevskaia VF, Buval'tsev VI, Boronenkov GM.
    Kardiologiia; 2002 Sep 22; 42(8):20-4. PubMed ID: 12494089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.